George Orphanos
About
In The Last Decade
George Orphanos
17 papers receiving 428 citations
Peers
Comparison fields: 5 of 66
- Oncology 225
- Molecular Biology 107
- Cardiology and Cardiovascular Medicine 106
- Pulmonary and Respiratory Medicine 99
- Immunology 73
Countries citing papers authored by George Orphanos
This map shows the geographic impact of George Orphanos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Orphanos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Orphanos more than expected).
Fields of papers citing papers by George Orphanos
This network shows the impact of papers produced by George Orphanos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Orphanos. The network helps show where George Orphanos may publish in the future.
Co-authorship network of co-authors of George Orphanos
This figure shows the co-authorship network connecting the top 25 collaborators of George Orphanos. A scholar is included among the top collaborators of George Orphanos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George Orphanos. George Orphanos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 1 | |
| 3 | 24 | |
| 4 | 2 | |
| 5 | 14 | |
| 6 | 11 | |
| 7 | 208 | |
| 8 | 7 | |
| 9 | 21 | |
| 10 | Systemic sclerosis associated with rectal cancer. Case report and a brief review of the literature. | 5 |
| 11 | 9 | |
| 12 | Is overcoming hormone resistance in breast cancer possible? | 3 |
| 13 | Low-dose capecitabine in breast cancer patients with symptomatic bone marrow infiltration: a case study. | 11 |
| 14 | 84 | |
| 15 | Skin metastases from primary lung cancer. Report of three cases and a brief review. | 7 |
| 16 | 2 | |
| 17 | Salvage treatment with single-agent capecitabine in patients with heavily pretreated advanced colorectal cancer. | 9 |
| 18 | 19 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.